Susan Moran
Director · CRESCENT BIOPHARMA, INC.
Individual
- 2025
- Jun 3, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Susan Moran files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $20.00M in CBIO purchases and sales in the last 12 months
- Robert J. More - $5.25M in TYRA purchases and sales in the last 12 months
- Daniel Bensen - $4.81M in TYRA purchases and sales in the last 12 months
- Joshua T. Brumm - $921K in CBIO purchases and sales in the last 12 months
- Gilla Kaplan - $529K in TYRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Susan Moran?
Susan Moran is a corporate insider, tracked as Director of CRESCENT BIOPHARMA, INC. (CBIO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Susan Moran last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 3 filings going back to 2025.
